Impressive Q2 Performance Drives Further Guidance Raise At ANI

Firm Now Anticipates 2023 Net Revenue Between $425m And $445m

 
• By Chloe Kent
  
Vector of a businessman blowing a horn shaped like a dollar sign
ANI's performance was driven by generic products and Cortrophin gel • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business